INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 47m ago
HOUSE PTR7m ago
SEC 13F7m ago
ROBINHOOD CHAIN7m ago
SEC FORM 4/Open-market saleVerified data

Holloway Jean F sold AORT

SVP, General Counsel · ARTIVION, INC. · Common Stock

Side
SELL
Value
$239K
Shares
5,267
Price
$45.3
Executed
Dec 3, 2025
Disclosed
Dec 4, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 3 executedDec 4, 2025 disclosed

AORT · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
29/ 100 · ROUTINE
Methodology →
  • Transaction type+12 / 20

    Open-market sale

  • Relative size+4 / 25

    $239K reported value · 3.3% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+5 / 15

    1 other actor traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · AORT

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    35
    GM
    Green Andrew MSVP, Regulatory and Quality
    AORTARTIVION, INC.
    Open-market sale
    		SELL$287K
    11.5K sh
    		Sep 10, 2026Sep 11, 2026
    traded Sep 10, 2026
    		+1dSEC FORM 4

    Evidence

    20
    Gilbert Ray Cisneros, Jr.DSelf
    AORTARTIVION, INC.
    Purchase
    		BUY$1,001 – $15KAug 20, 2026Sep 10, 2026
    traded Aug 20, 2026
    		+21dHOUSE PTR

    Evidence

    39
    Gilbert Ray Cisneros, Jr.DSelf
    AORTARTIVION, INC.
    Purchase
    		BUY$1,001 – $15KJul 16, 2026Sep 4, 2026
    traded Jul 16, 2026
    		+50dHOUSE PTR

    Evidence

    5
    MP
    Mackin James PPresident & CEO
    AORTARTIVION, INC.
    Option exercise · 10b5-1 plan
    		M$916K
    30.9K sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    29
    HF
    Holloway Jean FSVP, General Counsel
    AORTARTIVION, INC.
    Open-market sale
    		SELL$93K
    2,048 sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    19
    MP
    Mackin James PPresident & CEO
    AORTARTIVION, INC.
    Open-market sale · 10b5-1 plan
    		SELL$1.41M
    30.9K sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    0
    MP
    Mackin James PPresident & CEO
    AORTARTIVION, INC.
    Option exercise · 10b5-1 plan
    		M—
    30.9K sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001628280-25-055463
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Dec 3, 2025
    Published
    Dec 4, 2025
    Ingested by INSIDER
    Nov 5, 04:29 UTC
    Last re-read
    Nov 5, 04:29 UTC

    Extracted facts

    Filer
    Holloway Jean F
    Role
    SVP, General Counsel
    Transaction
    Open-market saleAs filed: “S”
    Asset
    ARTIVION, INC.
    Ticker
    AORT
    Shares
    5,267
    Price per share
    $45.3
    Value
    $238,595
    Execution date (reported)
    Dec 3, 2025
    Owned after transaction
    156.1K shares
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 5,267
    • Price: $45.3

    = $238,595

    What this establishes

    Holloway Jean F filed this Form 4 reporting a open-market sale of AORT on Dec 3, 2025. It became public on Dec 4, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    SVP, General Counsel
    Holloway Jean Fcik:0001540065
    Issuer
    ARTIVION, INC.cik:0000784199

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.